Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and decursin

phorbol 12,13-dibutyrate has been researched along with decursin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, KS; Choi, SY; Choung, SY; Han, H; Kim, HH; Kim, IH	1

Other Studies

1 other study(ies) available for phorbol 12,13-dibutyrate and decursin

Article	Year
Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells. Leukemia research, 2005, Volume: 29, Issue:12 Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Benzopyrans; Butyrates; Cell Differentiation; Down-Regulation; Enzyme Activation; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Megakaryocytes; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyranocoumarins	2005

Article

Year

Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.

Leukemia research, 2005, Volume: 29, Issue:12

Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Benzopyrans; Butyrates; Cell Differentiation; Down-Regulation; Enzyme Activation; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Megakaryocytes; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyranocoumarins

2005